☰

Fredrik Romi - Publications

Affiliations: 
2001 University of Bergen, Norway, Bergen, Hordaland, Norway 
Tree Info Grants Similar researchers PubMed Report error

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hong Y, Skeie GO, Zisimopoulou P, Karagiorgou K, Tzartos SJ, Gao X, Yue YX, Romi F, Zhang X, Li HF, Gilhus NE. Retraction Note to: Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms. Journal of Neurology. PMID 30972499 DOI: 10.1007/S00415-019-09292-2  0.464
2018 Hong Y, Li HF, Romi F, Skeie GO, Gilhus NE. HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis. Acta Neurologica Scandinavica. PMID 29736936 DOI: 10.1111/Ane.12951  0.698
2018 Gilhus NE, Romi F, Hong Y, Skeie GO. Myasthenia gravis and infectious disease. Journal of Neurology. PMID 29372387 DOI: 10.1007/S00415-018-8751-9  0.559
2017 Romi F, Hong Y, Gilhus NE. Pathophysiology and immunological profile of myasthenia gravis and its subgroups. Current Opinion in Immunology. 49: 9-13. PMID 28780294 DOI: 10.1016/J.Coi.2017.07.006  0.736
2017 Hong Y, Zisimopoulou P, Trakas N, Karagiorgou K, Stergiou C, Skeie GO, Hao HJ, Gao X, Owe JF, Zhang X, Yue YX, Romi F, Wang Q, Li HF, Gilhus NE, et al. Multiple antibody detection in 'seronegative' myasthenia gravis patients. European Journal of Neurology. PMID 28470860 DOI: 10.1111/Ene.13300  0.764
2017 Hong Y, Skeie GO, Zisimopoulou P, Karagiorgou K, Tzartos SJ, Gao X, Yue YX, Romi F, Zhang X, Li HF, Gilhus NE. Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms. Journal of Neurology. PMID 28364296 DOI: 10.1007/S00415-017-8478-Z  0.702
2016 Hong Y, Li HF, Skeie GO, Romi F, Hao HJ, Zhang X, Gao X, Owe JF, Gilhus NE. Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients. Journal of Neuroimmunology. 298: 51-7. PMID 27609275 DOI: 10.1016/J.Jneuroim.2016.07.001  0.747
2016 Gilhus NE, Skeie GO, Romi F, Lazaridis K, Zisimopoulou P, Tzartos S. Myasthenia gravis - autoantibody characteristics and their implications for therapy. Nature Reviews. Neurology. 12: 259-68. PMID 27103470 DOI: 10.1038/Nrneurol.2016.44  0.721
2014 Heldal AT, Eide GE, Romi F, Owe JF, Gilhus NE. Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development. Plos One. 9: e114060. PMID 25464006 DOI: 10.1371/Journal.Pone.0114060  0.679
2012 Heldal AT, Eide GE, Gilhus NE, Romi F. Geographical distribution of a seropositive myasthenia gravis population. Muscle & Nerve. 45: 815-9. PMID 22581533 DOI: 10.1002/Mus.23271  0.59
2012 Romi F, Helgeland G, Gilhus NE. Serum levels of matrix metalloproteinases: implications in clinical neurology. European Neurology. 67: 121-8. PMID 22262194 DOI: 10.1159/000334862  0.482
2012 Romi F, Suzuki S, Suzuki N, Petzold A, Plant GT, Gilhus NE. Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis. Journal of Neurology. 259: 1312-6. PMID 22167224 DOI: 10.1007/S00415-011-6344-Y  0.74
2011 Gilhus NE, Owe JF, Hoff JM, Romi F, Skeie GO, Aarli JA. Myasthenia gravis: a review of available treatment approaches. Autoimmune Diseases. 2011: 847393. PMID 22007295 DOI: 10.4061/2011/847393  0.815
2011 Romi F. Thymoma in myasthenia gravis: from diagnosis to treatment. Autoimmune Diseases. 2011: 474512. PMID 21860784 DOI: 10.4061/2011/474512  0.654
2011 Luckman SP, Gilhus NE, Romi F. Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls. Autoimmune Diseases. 2011: 151258. PMID 21826262 DOI: 10.4061/2011/151258  0.56
2011 Romi F, Helgeland G, Gilhus NE. Heat-shock proteins in clinical neurology. European Neurology. 66: 65-9. PMID 21757921 DOI: 10.1159/000329373  0.603
2011 Helgeland G, Petzold A, Luckman SP, Gilhus NE, Plant GT, Romi FR. Matrix metalloproteinases in myasthenia gravis. European Neurology. 65: 53-8. PMID 21212676 DOI: 10.1159/000322737  0.65
2010 Helgeland G, Petzold A, Hoff JM, Gilhus NE, Plant GT, Romi FR. Anti-Heat Shock Protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome. Journal of Neuroimmunology. 225: 180-3. PMID 20554026 DOI: 10.1016/J.Jneuroim.2010.04.024  0.816
2010 Owe JF, Cvancarova M, Romi F, Gilhus NE. Extrathymic malignancies in thymoma patients with and without myasthenia gravis. Journal of the Neurological Sciences. 290: 66-9. PMID 20034637 DOI: 10.1016/J.Jns.2009.11.006  0.589
2009 Heldal AT, Owe JF, Gilhus NE, Romi F. Seropositive myasthenia gravis: a nationwide epidemiologic study. Neurology. 73: 150-1. PMID 19597135 DOI: 10.1212/Wnl.0B013E3181Ad53C2  0.7
2009 Aarli JA, Gilhus NE, Romi F, Skeie GO. Myasthenia gravis in the elderly Aging Health. 5: 561-568. DOI: 10.2217/Ahe.09.44  0.613
2008 Skeie GO, Romi F. Paraneoplastic myasthenia gravis: immunological and clinical aspects. European Journal of Neurology. 15: 1029-1033. PMID 18717725 DOI: 10.1111/J.1468-1331.2008.02242.X  0.638
2008 Helgeland G, Luckman SP, Romi FR, Jonassen AK, Gilhus NE. Myasthenia gravis sera have no effect on cardiomyocytes in vitro. Journal of Neuroimmunology. 201: 74-9. PMID 18632164 DOI: 10.1016/J.Jneuroim.2008.05.021  0.568
2008 Romi FR, Gilhus NE, Luckman SP. Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis. Journal of Neuroimmunology. 195: 96-9. PMID 18262287 DOI: 10.1016/J.Jneuroim.2007.10.018  0.514
2008 Aarli JA, Gilhus NE, Romi F, Skeie GO. Titin and ryanodine receptor antibodies and neuromuscular involvement in myasthenia gravis Future Neurology. 3: 87-92. DOI: 10.2217/14796708.3.1.87  0.814
2007 Romi F, Aarli JA, Gilhus NE. Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features. European Journal of Neurology. 14: 617-620. PMID 17539937 DOI: 10.1111/J.1468-1331.2007.01785.X  0.813
2006 Romi F, Gilhus NE, Aarli JA. Myasthenia gravis: disease severity and prognosis. Acta Neurologica Scandinavica. 113: 24-25. PMID 16637923 DOI: 10.1111/J.1600-0404.2006.00609.X  0.765
2005 Romi F, Aarli JA, Gilhus NE. Seronegative myasthenia gravis: disease severity and prognosis. European Journal of Neurology. 12: 413-418. PMID 15885043 DOI: 10.1111/J.1468-1331.2005.01137.X  0.817
2005 Romi F, Skeie GO, Gilhus NE, Aarli JA. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Archives of Neurology. 62: 442-6. PMID 15767509 DOI: 10.1001/Archneur.62.3.442  0.758
2005 Romi F, Gilhus NE, Aarli JA. Myasthenia gravis: clinical, immunological, and therapeutic advances. Acta Neurologica Scandinavica. 111: 134-141. PMID 15644074 DOI: 10.1111/J.1600-0404.2005.00374.X  0.624
2005 Romi F, Kristoffersen EK, Aarli JA, Gilhus NE. The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo. Journal of Neuroimmunology. 158: 191-4. PMID 15589053 DOI: 10.1016/J.Jneuroim.2004.08.002  0.724
2004 Romi F, Gilhus NE, Aarli JA. [Thymectomy and muscle antibodies in myasthenia gravis]. Tidsskrift For Den Norske Laegeforening : Tidsskrift For Praktisk Medicin, Ny Raekke. 124: 629-31. PMID 15004605  0.704
2004 Romi F, Kråkenes J, Aarli J, Tysnes O. Neuroborreliosis with Vasculitis Causing Stroke-Like Manifestations European Neurology. 51: 49-50. DOI: 10.1159/000075090  0.475
2003 Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA. Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study European Journal of Neurology. 10: 701-706. PMID 14641516 DOI: 10.1046/J.1468-1331.2003.00678.X  0.789
2003 Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis. Annals of the New York Academy of Sciences. 998: 481-90. PMID 14592917 DOI: 10.1196/Annals.1254.062  0.804
2003 Agius MA, Richman DP, Fairclough RH, Aarli J, Gilhus NE, Romi F. Three forms of immune myasthenia. Annals of the New York Academy of Sciences. 998: 453-6. PMID 14592914 DOI: 10.1196/Annals.1254.059  0.732
2003 Skeie GO, Romi F, Aarli JA, Bentsen PT, Gilhus NE. Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies. Annals of the New York Academy of Sciences. 998: 343-50. PMID 14592894 DOI: 10.1196/Annals.1254.039  0.792
2003 Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA. Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies. European Neurology. 49: 210-217. PMID 12736536 DOI: 10.1159/000070185  0.807
2002 Romi F, Bø L, Skeie GO, Myking A, Aarli JA, Gilhus NE. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. Journal of Neuroimmunology. 128: 82-9. PMID 12098514 DOI: 10.1016/S0165-5728(02)00145-5  0.787
2002 Romi F, Tysnes OB, Kråkenes J, Savoiardo M, Aarli JA, Bindoff L. Cystic dilation of Virchow-Robin spaces in the midbrain. European Neurology. 47: 186-8. PMID 11914561 DOI: 10.1159/000047982  0.454
2002 Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. European Journal of Neurology. 9: 55-61. PMID 11784377 DOI: 10.1046/J.1468-1331.2002.00352.X  0.82
2000 Romi F, Skeie GO, Aarli JA, Gilhus NE. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Jama Neurology. 57: 1596-1600. PMID 11074791 DOI: 10.1001/Archneur.57.11.1596  0.816
2000 Romi F, Skeie GO, Vedeler C, Aarli JA, Zorzato F, Gilhus NE. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations. Journal of Neuroimmunology. 111: 169-76. PMID 11063835 DOI: 10.1016/S0165-5728(00)00394-5  0.796
2000 Romi F, Skeie GO, Aarli JA, Gilhus NE. Muscle autoantibodies in subgroups of myasthenia gravis patients. Journal of Neurology. 247: 369-375. PMID 10896269 DOI: 10.1007/S004150050604  0.791
Show low-probability matches.